Blaze.tech's HIPAA-Compliant Builder Is Landing Inside Healthcare's Back Office

The no-code platform, built by a founder with a prior SaaS exit, is carving a niche in regulated industries where security is the product.

About Blaze.tech

Published

In healthcare, the distance between a clinician's need and a functional piece of software is often measured in budget cycles and developer sprints. Blaze.tech, a Los Angeles-based startup, is betting that distance can be collapsed into a drag-and-drop canvas, provided the canvas itself meets a critical threshold: it must be secure and compliant by design [TechCrunch, January 2023].

A wedge into regulated workflows

Blaze launched in early 2023 as a general-purpose no-code platform for building internal business tools. Its initial pitch focused on empowering non-technical teams to create applications like inventory managers, customer portals, and automated invoicing systems by connecting data from sources like Airtable and Google Sheets [Built In LA, January 2023]. Yet, from the start, the company's public messaging carried a distinct and deliberate focus. It marketed itself not just as a builder, but specifically as a "HIPAA-compliant app builder for healthcare" [blaze.tech, retrieved 2024]. By baking compliance into the platform's architecture, Blaze aims to serve organizations where data security is a regulatory and ethical imperative.

The founder's second act

The company's credibility in pursuing this complex sector rests significantly on the track record of co-founder Nanxi Liu. Prior to Blaze, Liu was the CEO and co-founder of Enplug, a digital signage software company that scaled to serve Fortune 500 clients before its acquisition by Spectrio in 2021 [TechCrunch, January 2023]. This experience provides a playbook for enterprise SaaS sales and an understanding of building software for large, distributed organizations. Liu co-founded Blaze with Saeed Ganji and Justyna Wojcik [Blaze.tech | LinkedIn, retrieved 2026].

Early traction and the competitive field

Blaze announced a $3.5 million pre-seed round in January 2023, led by Flybridge Capital and MaC Venture Capital [Built In LA, January 2023]. A seed round was later noted, though its details remain undisclosed [CB Insights, October 2023]. The company operates in a competitive arena dominated by well-funded players like Retool, Bubble, and Glide.

Blaze's differentiation appears to hinge on three interconnected claims:

  • Compliance as core. Positioning the platform as inherently compliant for regulated industries, notably healthcare.
  • Complexity tolerance. Supporting "very custom, complex, highly secure applications" beyond simple forms or websites [TechCrunch, January 2023].
  • AI-assisted development. Incorporating AI to guide app creation and configuration.

The platform's use cases include patient portals, telehealth apps, and scheduling tools built for healthcare organizations [blaze.tech, retrieved 2026]. One cited deployment involves powering a HIPAA-compliant telehealth platform for a company called Kiaora [blaze.tech, retrieved 2026].

Selected No-Code Platform Competitors Primary Focus Notable Differentiation
Blaze.tech Complex, secure internal apps HIPAA-compliant builder for healthcare
Retool Developer-led internal tools Extensive code-level customization
Bubble General web application builder Strong front-end design flexibility
Glide Mobile apps from spreadsheets Extreme simplicity for basic apps

Navigating the risks of specialization

The bet on healthcare and compliance is ambitious, but it carries inherent execution risks. The first is market size. By focusing intently on regulated workflows, Blaze may be trading the vast total addressable market of general business automation for a deeper, but narrower, niche. The second risk is trust. In healthcare, a platform's security claims are scrutinized by legal and compliance officers. Finally, there is the competitive response. Larger players like Retool or Microsoft's Power Platform could decide to deepen their own compliance offerings.

The next twelve months

The coming year will be critical for Blaze to transition from an interesting pre-seed story to a company with measurable commercial momentum. Key milestones to watch will include the announcement of named enterprise healthcare customers beyond early adopters, the expansion of its compliance certifications to other regulated sectors, and clarity on its seed round funding and valuation.

For patients and clinicians, the disease states in question are often administrative: fragmented data, manual referral tracking, siloed communication channels. Blaze.tech is proposing a different path, one where the teams closest to the problem can build the precise tool they need, without sacrificing the security that patient care demands.

Read on Startuply.vc